POINT Biopharma Global Inc. PNT NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score

61/100

3/7 Pass

SharesGrow Intrinsic Value

共有 50 笔近期内部人交易记录记录，涉及 POINT Biopharma Global Inc. (PNT), 包括 25 笔买入 和 21 笔卖出. 内部人买入总额为 $14.9M 内部人卖出总额为 $70.58M.

近期活跃的重要内部人包括 Silber Allan C, Lubner David Charles, Malik Rajesh. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.

内部人交易记录 — PNT

日期	姓名	职位	交易类型	股数	平均价格	总价值	持股数量
2023-12-27	Silber Allan C	Executive Chairman	股份退回	537,322	$6.78	$3.64M	-
2023-12-27	Lubner David Charles	Director	股份退回	44,749	$9.12	$408.11K	-
2023-12-27	Malik Rajesh	Director	股份退回	44,749	$9.12	$408.11K	-
2023-12-27	Fleshner Neil E.	Chief Medical Officer	股份退回	84,257	$6.78	$571.26K	-
2023-12-27	Demers William L.	Chief Financial Officer	股份退回	131,355	$6.78	$890.59K	-
2023-12-27	Goodman Jonathan R.	Director	股份退回	44,749	$9.12	$408.11K	-
2023-12-27	Margolin Yael	Director	股份退回	44,749	$9.12	$408.11K	-
2023-12-27	Mccann Joe A.	Chief Executive Officer	股份退回	692,643	$6.78	$4.7M	-
2023-12-27	Hogue Gerald L.	Director	股份退回	44,749	$9.12	$408.11K	-
2023-12-27	Jensen Jessica D.	EVP Clinical Development	股份退回	136,055	$6.78	$922.45K	-
2023-12-27	Kelly Justyna	Chief Operating Officer	股份退回	98,358	$6.78	$666.87K	-
2023-12-26	Lubner David Charles	Director	要约收购（卖出）	35,400	$12.50	$442.5K	3,600
2023-12-26	Malik Rajesh	Director	要约收购（卖出）	3,700	$12.50	$46.25K	-
2023-12-26	Goodman Jonathan R.	Director	要约收购（卖出）	41,872	$12.50	$523.4K	-
2023-12-26	Hogue Gerald L.	Director	要约收购（卖出）	21,596	$12.50	$269.95K	-
2023-12-22	Silber Allan C	Executive Chairman	要约收购（卖出）	71,744	$12.50	$896.8K	-
2023-12-22	Fleshner Neil E.	Chief Medical Officer	要约收购（卖出）	358	$12.50	$4.48K	-
2023-12-22	Mccann Joe A.	Chief Executive Officer	要约收购（卖出）	3,494,153	$12.50	$43.68M	-
2023-12-18	Bvf Partners L P/il	Officer	知情卖出	896,366	$12.45	$11.16M	-
2023-11-06	Mccann Joe A.	Chief Executive Officer	赠与（送出）	120,000	-	-	3,494,153
2023-11-03	Silber Allan C	Executive Chairman	赠与（送出）	500,000	-	-	38,087
2023-11-02	Bvf Partners L P/il	10 Percent Owner	处置	-	-	-	896,366
2023-10-31	Fleshner Neil E.	Chief Medical Officer	赠与（送出）	250,000	-	-	2,773,045
2023-06-13	Martell Bridget A	Director	限制性股票授予 (RSU)	80,503	$10.08	$811.47K	80,503
2023-06-12	Martell Bridget A	Director	未知	-	-	-	-
2023-06-01	Lubner David Charles	Director	限制性股票授予 (RSU)	44,749	$9.12	$408.11K	44,749
2023-06-01	Malik Rajesh	Director	限制性股票授予 (RSU)	44,749	$9.12	$408.11K	44,749
2023-06-01	Goodman Jonathan R.	Director	限制性股票授予 (RSU)	44,749	$9.12	$408.11K	44,749
2023-06-01	Margolin Yael	Director	限制性股票授予 (RSU)	44,749	$9.12	$408.11K	44,749
2023-06-01	Hogue Gerald L.	Director	限制性股票授予 (RSU)	44,749	$9.12	$408.11K	44,749
2023-03-28	Silber Allan C	10 Percent Owner, Officer: Executive Chairman	限制性股票授予 (RSU)	537,322	$6.78	$3.64M	537,322
2023-03-28	Fleshner Neil E.	Chief Medical Officer	限制性股票授予 (RSU)	84,257	$6.78	$571.26K	84,257
2023-03-28	Demers William L.	Chief Financial Officer	限制性股票授予 (RSU)	131,355	$6.78	$890.59K	131,355
2023-03-28	Mccann Joe A.	Chief Executive Officer	限制性股票授予 (RSU)	692,643	$6.78	$4.7M	692,643
2023-03-28	Jensen Jessica D.	EVP Clinical Development	限制性股票授予 (RSU)	136,055	$6.78	$922.45K	136,055
2023-03-28	Kelly Justyna	Chief Operating Officer	限制性股票授予 (RSU)	98,358	$6.78	$666.87K	98,358
2023-03-21	Hogue Gerald L.	Director	期权行权（卖出）	17,936	$6.97	$125.01K	17,936
2022-11-29	Mccann Joe A.	Chief Executive Officer	知情买入	2,160	$6.64	$14.34K	3,616,313
2022-11-28	Malik Rajesh	Director	知情买入	3,700	$6.66	$24.64K	3,700
2022-11-25	Hogue Gerald L.	Director	知情买入	3,660	$6.82	$24.94K	3,660
2022-11-23	Lubner David Charles	Director	知情买入	3,600	$6.85	$24.66K	3,600
2022-11-21	Margolin Yael	Director	知情买入	1,710	$6.56	$11.22K	1,710
2022-11-18	Silber Allan C	Executive Chairman	知情买入	22,397	$6.50	$145.58K	4,268,605
2022-11-18	Goodman Jonathan R.	Director	知情买入	6,000	$6.33	$37.98K	41,872
2022-11-17	Silber Allan C	Executive Chairman	知情买入	27,603	$6.00	$165.62K	4,246,208
2022-06-02	Lubner David Charles	Director	限制性股票授予 (RSU)	25,614	$8.31	$212.85K	25,614
2022-06-02	Malik Rajesh	Director	限制性股票授予 (RSU)	25,614	-	-	25,614
2022-06-02	Goodman Jonathan R.	Director	限制性股票授予 (RSU)	25,614	-	-	25,614
2022-06-02	Margolin Yael	Director	限制性股票授予 (RSU)	25,614	-	-	25,614
2022-06-02	Hogue Gerald L.	Director	限制性股票授予 (RSU)	25,614	-	-	25,614